USE OF HIGH-INTENSITY STATIN THERAPY POST-ACUTE CORONARY SYNDROME IN THE ONGOING ODYSSEY OUTCOMES TRIAL OF ALIROCUMAB, A PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 MONOCLONAL ANTIBODY, VERSUS PLACEBO: INTERIM BASELINE DATA
Goodman, Shaun G., Schwartz, Gregory, Bhatt, Deepak L., Bittner, Vera, Diaz, Rafael, Hanotin, Corinne, Harrington, Robert, Jukema, Johan, Moryusef, Angele, Pordy, Robert, Roe, Matthew, Sasiela, WilliaVolume:
69
Language:
english
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/s0735-1097(17)33542-8
Date:
March, 2017
File:
PDF, 381 KB
english, 2017